Depression Doctors & TMS Program
31 East Darrah Lane, Suite 104, Lawrence Township
4.8(52 Google reviews)
United States
3 listed treatment centers serving Trenton and the surrounding area.
31 East Darrah Lane, Suite 104, Lawrence Township
4.8(52 Google reviews)
105 Evesboro - Medford Road, Suite L, Evesham
5.0(34 Google reviews)
Before starting SPRAVATO®, ask for a written explanation of the expected charges and how your insurance will handle them. Both the medication and the observed treatment and monitoring visit may be billed. Your share depends on your benefits, the treatment setting, and whether the providers involved are in network. A medication benefit check alone may not explain the full cost of a visit.
Prior authorization is common. Your insurer may require documentation of earlier antidepressant trials before deciding whether to approve treatment. Ask the center which records it needs from previous prescribers and who will submit the authorization request. Confirm whether approval covers both the medicine and the services provided during each visit, and ask about renewal requirements.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. New Jersey Medicaid coverage also depends on the plan and setting. Neither participation in Medicare or Medicaid nor payment for Spravato should be assumed for an individual center; verify both directly.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules and which charges, if any, a program helps with.
Before scheduling, ask the center and insurer:
Also budget for transportation and time away from work.
SPRAVATO® treatment takes place only in a healthcare setting certified through the SPRAVATO® REMS safety program. You self-administer the nasal spray under direct observation of a healthcare provider; it is never sent home with you. Before booking, confirm the location’s current certification and whether it is accepting new patients.
For treatment-resistant depression, the typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume appointments will automatically become less frequent on a particular date.
Plan for at least two hours of monitoring after each dose, plus check-in, preparation, and discharge. The complete appointment may take longer. When arranging time off work, include the full visit and transportation rather than budgeting only for the spray itself. Ask whether appointment times can fit your work or caregiving responsibilities.
You need someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every visit and a backup if your driver becomes unavailable. Ask the center about its discharge and pickup requirements before relying on a ride service.
If you cannot find an available listed center in Trenton, listings also identify Spravato services in Lawrence Township, Princeton, and Evesham. Those listings do not confirm REMS certification. Contact each location to verify certification, availability, and insurance participation before planning travel or transferring records.
Ask any center you are considering to confirm that the specific treatment location is currently certified through the SPRAVATO® REMS program. A directory listing alone does not establish certification. Listings identify Spravato services in Lawrence Township, Princeton, and Evesham, but their certification status is unconfirmed here. Also check appointment availability and insurance participation directly.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must assess your diagnosis, treatment history, and safety considerations before recommending it.
Coverage depends on your plan and the treatment setting. Prior authorization and records of previous antidepressant trials are commonly required. Ask your insurer about both the medication and the monitored visit, including network status and your share of each charge. Medicare and New Jersey Medicaid may cover treatment depending on the plan and setting; confirm rather than assuming a listed center accepts your coverage.
You use the nasal spray yourself under direct observation in a REMS-certified healthcare setting. Staff monitor you for at least two hours after the dose for effects such as sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for preparation and discharge. Arrange a driver home: you cannot drive until the next day after a restful sleep.
Ask about sedation, dissociation—a feeling of disconnection—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history and medications with the prescriber, and tell staff immediately if you feel unwell during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment consultation if you need urgent help. In a crisis, call or text 988. If there is immediate danger or a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.